Clinical Trial Examining the Short and Long-term Effect of Myofascial Trigger Points Injection in Low Back Pain Patients
NCT ID: NCT01520415
Last Updated: 2013-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
40 participants
INTERVENTIONAL
2012-01-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multi-modal Imaging of Myofascial Pain - Phase 2
NCT07322445
Treatment of Myofascial Pain Syndrome With Lidocaine Injection and Physical Therapy.
NCT01250184
Trigger Point Injection for Myofascial Pain Syndrome in the Low Back: A Randomized Controlled Trial
NCT04704297
Facet Versus Trigger Point Injections for Chronic Neck Pain
NCT01808586
Investigating the Minimum Number of Needling Required to Optimize Trigger Point Injections Outcome
NCT04732507
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bupivacaine
Bupivacaine
2ml per injection up to a maximum of 8ml (4 identified trigger points) per visit
saline
Saline
2ml per injection up to a maximum of 8ml (4 identified trigger points) per visit
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bupivacaine
2ml per injection up to a maximum of 8ml (4 identified trigger points) per visit
Saline
2ml per injection up to a maximum of 8ml (4 identified trigger points) per visit
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* MPS as evident by at least one active MTP, located medial or lateral to the posterior iliac crest involving the gluteus maximus or medius, quadratus lumborum and erector spinae muscles
* While not precluding the participation in the study, MTP in other areas will not make patients eligible
* Pain lasting for at least six months
Exclusion Criteria
* Any injection or nerve block in the low back in the last 6 months
* Local or systemic infection
* Bleeding disorder or the use of anticoagulation medications
* Known allergy to local anesthetics
* Poor understanding of written and spoken English or French
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Yoram Shir
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Yoram Shir
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yoram Shir, MD
Role: PRINCIPAL_INVESTIGATOR
MUHC-RI
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alan Edwards Pain Management Unit - Montreal General Hospital
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AEPMU-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.